Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -446,444 | -266,031 | -151,080 | -569,183 | -435,798 |
| Depreciation Amortization | 22,731 | 14,829 | 7,257 | 22,919 | 16,646 |
| Accounts receivable | 2,834 | -2,591 | 10,062 | -33,598 | -12,958 |
| Other Working Capital | -23,588 | -78,447 | -56,633 | 13,918 | -8,833 |
| Other Operating Activity | 78,296 | 57,492 | 23,919 | 151,756 | 106,258 |
| Operating Cash Flow | $-366,171 | $-274,748 | $-166,475 | $-414,188 | $-334,685 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 329,582 | 210,794 | 136,994 | 4,659 | -98,857 |
| PPE Investments | -5,062 | -3,784 | -1,324 | -7,491 | -6,837 |
| Sale Of Investment | N/A | 143 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -15,000 | -15,000 | -15,000 | -12,500 | -12,500 |
| Other Investing Activity | -16,273 | -16,088 | -15,780 | -14,936 | -14,809 |
| Investing Cash Flow | $308,247 | $191,065 | $119,890 | $-17,768 | $-120,503 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 83,808 | 83,806 | 157 | 399,241 | 396,055 |
| Financing Cash Flow | $83,808 | $83,806 | $157 | $399,241 | $396,055 |
| Exchange Rate Effect | 4,656 | 4,362 | 1,448 | -2,525 | -52 |
| Beginning Cash Position | 184,159 | 184,159 | 184,159 | 219,399 | 219,399 |
| End Cash Position | 214,699 | 188,644 | 139,179 | 184,159 | 160,214 |
| Net Cash Flow | $30,540 | $4,485 | $-44,980 | $-35,240 | $-59,185 |
| Free Cash Flow | |||||
| Operating Cash Flow | -366,171 | -274,748 | -166,475 | -414,188 | -334,685 |
| Capital Expenditure | -5,062 | -3,784 | -1,324 | -7,491 | -6,837 |
| Free Cash Flow | -371,233 | -278,532 | -167,799 | -421,679 | -341,522 |